These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17021713)

  • 1. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.
    Yiannopoulos G; Pastromas V; Antonopoulos I; Katsiberis G; Kalliolias G; Liossis SN; Andonopoulos AP
    Rheumatol Int; 2007 Feb; 27(4):357-61. PubMed ID: 17021713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
    Griffiths B; Miles S; Moss H; Robertson R; Veale D; Emery P
    J Rheumatol; 2002 Nov; 29(11):2371-8. PubMed ID: 12415594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.
    Airò P; Danieli E; Rossi M; Frassi M; Cavazzana I; Scarsi M; Grottolo A; Franceschini F; Zambruni A
    Clin Exp Rheumatol; 2007; 25(2):293-6. PubMed ID: 17543156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
    Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
    J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma.
    Davas EM; Peppas C; Maragou M; Alvanou E; Hondros D; Dantis PC
    Clin Rheumatol; 1999; 18(6):455-61. PubMed ID: 10638770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
    Abignano G; Bissell LA; Emery P; Del Galdo F; Buch MH
    Rheumatology (Oxford); 2016 Dec; 55(12):2273-2275. PubMed ID: 27744357
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
    Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
    Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up.
    Tochimoto A; Kawaguchi Y; Hara M; Tateishi M; Fukasawa C; Takagi K; Nishimagi E; Ota Y; Katsumata Y; Gono T; Tanaka E; Yamanaka H
    Mod Rheumatol; 2011 Jun; 21(3):296-301. PubMed ID: 21240620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.
    Vanthuyne M; Blockmans D; Westhovens R; Roufosse F; Cogan E; Coche E; Nzeusseu Toukap A; Depresseux G; Houssiau FA
    Clin Exp Rheumatol; 2007; 25(2):287-92. PubMed ID: 17543155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
    Pakas I; Ioannidis JP; Malagari K; Skopouli FN; Moutsopoulos HM; Vlachoyiannopoulos PG
    J Rheumatol; 2002 Feb; 29(2):298-304. PubMed ID: 11842824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
    Fraticelli P; Gabrielli B; Pomponio G; Valentini G; Bosello S; Riboldi P; Gerosa M; Faggioli P; Giacomelli R; Del Papa N; Gerli R; Lunardi C; Bombardieri S; Malorni W; Corvetta A; Moroncini G; Gabrielli A;
    Arthritis Res Ther; 2014 Jul; 16(4):R144. PubMed ID: 25007944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
    Iudici M; Cuomo G; Vettori S; Bocchino M; Sanduzzi Zamparelli A; Cappabianca S; Valentini G
    Semin Arthritis Rheum; 2015 Feb; 44(4):437-44. PubMed ID: 25282395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.
    Lorenzi AR; Johnson AH; Davies G; Gough A
    Ann Rheum Dis; 2001 Aug; 60(8):796-8. PubMed ID: 11454645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.
    Ostojic P; Damjanov N
    Clin Rheumatol; 2006 Nov; 25(6):819-21. PubMed ID: 16440134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases.
    Schnabel A; Reuter M; Gross WL
    Arthritis Rheum; 1998 Jul; 41(7):1215-20. PubMed ID: 9663478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are high doses of prednisone necessary for treatment of interstitial lung disease in systemic sclerosis?
    Pérez Campos D; Estévez Del Toro M; Peña Casanovas A; González Rojas PP; Morales Sánchez L; Gutiérrez Rojas AR
    Reumatol Clin; 2012; 8(2):58-62. PubMed ID: 22317852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.
    Takahashi T; Asano Y; Amiya E; Hatano M; Tamaki Z; Ozeki A; Watanabe A; Kawarasaki S; Nakao T; Taniguchi T; Ichimura Y; Toyama T; Watanabe M; Hirata Y; Nagai R; Sato S
    Mod Rheumatol; 2012 Aug; 22(4):598-601. PubMed ID: 22015621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.